CorrespondenceClosing the portal to SARS-CoV-2 cellular entry: May open newer avenues…
Keywords
Camostat mesylate
Cellular entry
COVID-19
Nafamostat mesylate
SARS-CoV-2 pneumonia
Thrombosis
Transmembrane protease serine 2 (TMPRSS2)
Cited by (0)
© 2020 Elsevier Ltd. All rights reserved.